Annonce • Jan 29
Ercros, S.A. to Report Fiscal Year 2025 Results on Feb 27, 2026 Ercros, S.A. announced that they will report fiscal year 2025 results on Feb 27, 2026 Annonce • Oct 12
Ercros, S.A. to Report Q3, 2025 Results on Nov 11, 2025 Ercros, S.A. announced that they will report Q3, 2025 results on Nov 11, 2025 Annonce • Aug 12
Esseco Industrial S.P.A. cancelled the acquisition of Ercros, S.A. (BME:ECR). Esseco Industrial S.P.A. made an offer to acquire Ercros, S.A. (BME:ECR) for approximately €350 million on June 19, 2024. A cash consideration valued at €3.84 per share will be paid by Esseco Industrial S.P.A. Under the terms, the compensation will be in cash and amounts to a maximum total of €351.1 million. Esseco will promote talent retention and maintain Ercros' headquarters in Barcelona. The offer price has been calculated on the basis that if the target company makes any distribution of dividends, the offer price would be reduced by an amount equivalent to the gross amount per share of such distribution.
The offer is addressed to the entire share capital of Ercros and is subject to a minimum acceptance condition of 75% as well as to the customary administrative and governmental authorisations for this type of transactions, which will be described in detail in the prospectus that will be made available to shareholders upon completion of its processing by the Comisión Nacional del Mercado de Valores. As of June 28, 2024, the general meeting has approved all the resolution proposals presented by the board of directors of Ercros. The management body of the Bidder approved by unanimity of all its directors on 19 June 2024 launching the Offer, subject to obtaining the necessary financing commitments to ensure the Offeror’s full payment of the cash consideration. As of July 11, 2024, In relation to the takeover bid presented by Bondalti for the capital of Ercros, the Portuguese company states that, as a result of the dividend charged to the 2023 profit of gross €0.096 per share that Ercros paid to its shareholders on July 10, 2024, Bidder has adjusted the Offer price, has deducted this amount from the takeover price and, after rounding the resulting figure, the price becomes €3.745 per share. The National Markets Commission (CNMC) has begun phase two of its analysis of Esseco's takeover bid for Ercros. The company has notified the National Securities Market Commission (CNMV), the stock market supervisor, of this step and has recalled that the CNMC's lack of opposition to the operation is one of the conditions to which the "effectiveness" of the offer is subject.
The board of directors and the management team of Ercros will continue to manage the Company's business diligently in the ordinary course of its activity, ensuring the corporate interest and with full respect for the obligations established by the applicable regulations, for which it has the advice from Evercore Partners International LLP, as financial advisor, and from Uría Menéndez Abogados, S.L.P., as legal advisor. Esseco has been advised by J.P. Morgan as financial advisor and Gianni & Origoni as well as Javier Carvajal, Javier Gómez and Teresa Méndez of Pérez-Llorca Abogados, S.L.P. as legal counsels.
Esseco Industrial S.P.A. cancelled the acquisition of Ercros, S.A. (BME:ECR) on August 11, 2025. Annonce • May 14
Ercros, S.A., Annual General Meeting, Jun 26, 2025 Ercros, S.A., Annual General Meeting, Jun 26, 2025. Location: avenida diagonal 514, planta 6., barcelona Spain Annonce • Apr 16
Ercros, S.A. to Report Q1, 2025 Results on May 13, 2025 Ercros, S.A. announced that they will report Q1, 2025 results on May 13, 2025 Annonce • Mar 05
Ercros, S.A. to Report Fiscal Year 2024 Final Results on Mar 31, 2025 Ercros, S.A. announced that they will report fiscal year 2024 final results at 5:30 PM, Romance Standard Time on Mar 31, 2025 Annonce • Jan 28
Ercros, S.A. to Report Second Half, 2024 Results on Feb 25, 2025 Ercros, S.A. announced that they will report second half, 2024 results on Feb 25, 2025 Reported Earnings • Nov 08
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: €173.5m (up 12% from 3Q 2023). Net loss: €9.20m (loss narrowed 15% from 3Q 2023). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Reported Earnings • Aug 01
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: €188.4m (down 11% from 2Q 2023). Net loss: €1.66m (down 143% from profit in 2Q 2023). Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Upcoming Dividend • Jul 01
Upcoming dividend of €0.078 per share Eligible shareholders must have bought the stock before 08 July 2024. Payment date: 10 July 2024. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 2.5%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.2%). Reported Earnings • May 02
First quarter 2024 earnings released First quarter 2024 results: EPS: €0.033. Revenue: €188.7m (down 14% from 1Q 2023). Net income: €3.05m (down 78% from 1Q 2023). Profit margin: 1.6% (down from 6.4% in 1Q 2023). Revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany. Valuation Update With 7 Day Price Move • Mar 06
Investor sentiment improves as stock rises 49% After last week's 49% share price gain to €3.39, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 16x in the Chemicals industry in Germany. Total returns to shareholders of 39% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €2.78 per share. Buy Or Sell Opportunity • Mar 06
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 40% to €3.39. The fair value is estimated to be €2.78, however this is not to be taken as a sell recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 4.8% per annum. Earnings are also forecast to grow by 7.6% per annum over the same time period. Annonce • Mar 05
Bondalti Ibérica launched a public takeover offer to acquire Ercros, S.A. (BME:ECR) for €340 million . Bondalti Ibérica launched a public takeover offer to acquire Ercros, S.A. (BME:ECR) for €340 million on March 5, 2024. Offer price is €3.6 per share. The transaction is still conditional on the acceptance of more than 75% of the capital and the obtaining of all relevant regulatory and governmental approvals. Reported Earnings • Mar 01
Full year 2023 earnings released Full year 2023 results: Revenue: €757.6m (down 26% from FY 2022). Net income: €28.8m (down 59% from FY 2022). Profit margin: 3.8% (down from 6.9% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Germany. New Risk • Nov 09
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 1.8% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 1.8% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.2% net profit margin). Annonce • Oct 18
Ercros, S.A. to Report Q3, 2023 Results on Nov 08, 2023 Ercros, S.A. announced that they will report Q3, 2023 results on Nov 08, 2023 New Risk • Jul 28
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 4.2% Last year net profit margin: 8.3% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (4.2% net profit margin). Reported Earnings • Jul 27
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: €222.4m (down 22% from 2Q 2022). Net income: €3.81m (down 87% from 2Q 2022). Profit margin: 1.7% (down from 10% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is expected to decline by 1.4% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.4%. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Board Change • Jul 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Proprietary Director Joan Galofre was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Jun 19
Upcoming dividend of €0.12 per share at 4.8% yield Eligible shareholders must have bought the stock before 26 June 2023. Payment date: 28 June 2023. Payout ratio is a comfortable 21% and this is well supported by cash flows. Trailing yield: 4.8%. Within top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.9%). Valuation Update With 7 Day Price Move • May 05
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to €3.62, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 14x in the Chemicals industry in Germany. Total returns to shareholders of 47% over the past three years. Buying Opportunity • May 05
Now 24% undervalued after recent price drop Over the last 90 days, the stock is down 1.4%. The fair value is estimated to be €4.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 48%. For the next 3 years, revenue is forecast to decline by 5.4% per annum. Earnings is also forecast to decline by 12% per annum over the same time period. Annonce • May 04
Ercros, S.A., Annual General Meeting, Jun 15, 2023 Ercros, S.A., Annual General Meeting, Jun 15, 2023, at 12:00 Central European Standard Time. Location: Uría Menéndez Auditorium, Avenida Diagonal 514, 6th floor Barcelona Spain Agenda: To consider financial statements and directors' report; to consider statement of non-financial information of the Company and its consolidated Group for the year ended 31 December 2022; to consider Re-election of Ernst & Young, S.L. as the auditor. Reported Earnings • Feb 24
Full year 2022 earnings released: EPS: €0.64 (vs €0.43 in FY 2021) Full year 2022 results: EPS: €0.64 (up from €0.43 in FY 2021). Revenue: €1.02b (up 28% from FY 2021). Net income: €70.6m (up 63% from FY 2021). Profit margin: 6.9% (up from 5.4% in FY 2021). The increase in margin was driven by higher revenue. Revenue is expected to decline by 8.9% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.3%. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth. Annonce • Jan 30
Ercros, S.A. to Report Fiscal Year 2022 Results on Feb 28, 2023 Ercros, S.A. announced that they will report fiscal year 2022 results on Feb 28, 2023 Annonce • Jan 25
Ercros, S.A. to Report Fiscal Year 2022 Results on Feb 22, 2023 Ercros, S.A. announced that they will report fiscal year 2022 results on Feb 22, 2023 Buying Opportunity • Nov 03
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 5.1%. The fair value is estimated to be €3.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 36%. Revenue is forecast to decline by 13% in 2 years. Earnings is forecast to decline by 36% in the next 2 years. Annonce • Oct 17
Ercros, S.A. to Report Q3, 2022 Results on Nov 15, 2022 Ercros, S.A. announced that they will report Q3, 2022 results on Nov 15, 2022 Annonce • Aug 02
Ercros, S.A. to Report Q2, 2022 Results on Aug 31, 2022 Ercros, S.A. announced that they will report Q2, 2022 results on Aug 31, 2022 Reported Earnings • Jul 30
Second quarter 2022 earnings released Second quarter 2022 results: Revenue: €297.7m (up 50% from 2Q 2021). Net income: €29.1m (up 152% from 2Q 2021). Profit margin: 9.8% (up from 5.8% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 3.5% compared to a 5.7% growth forecast for the industry in Germany. Annonce • Jun 30
Ercros, S.A. to Report First Half, 2022 Results on Jul 28, 2022 Ercros, S.A. announced that they will report first half, 2022 results on Jul 28, 2022 Upcoming Dividend • Jun 13
Upcoming dividend of €0.069 per share Eligible shareholders must have bought the stock before 20 June 2022. Payment date: 22 June 2022. Trailing yield: 2.4%. Lower than top quartile of German dividend payers (4.4%). Lower than average of industry peers (5.1%). Annonce • May 04
Ercros, S.A., Annual General Meeting, Jun 09, 2022 Ercros, S.A., Annual General Meeting, Jun 09, 2022, at 12:00 Central European Standard Time. Location: Mutua General de Seguros, calle Entenza, 325-335 Barcelona Spain Agenda: To approve the financial statements and directors' report of the company and its consolidated group; to approve the statement of non-financial information (annual corporate social responsibility report) of the company and its consolidated group for the year ended December 31, 2021; to consider reduction of the share capital by redemption of treasury shares charged to unrestricted reserves and excluding the right of creditors to object, and subsequent amendment of Article 3. `Share capital' in the Ercros, S.A. articles of association; to reelect Ernst & Young, S.L. as the auditor of the company and its consolidated group for 2022; to consider advisory vote on the annual directors remuneration report for 2021; and to consider other matters. Buying Opportunity • Apr 28
Now 21% undervalued Over the last 90 days, the stock is up 8.4%. The fair value is estimated to be €4.00, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 6.1%. Revenue is forecast to decline by 7.5% in 2 years. Earnings is forecast to decline by 13% in the next 2 years. Annonce • Apr 15
Ercros, S.A. to Report Q1, 2022 Results on May 14, 2022 Ercros, S.A. announced that they will report Q1, 2022 results on May 14, 2022 Reported Earnings • Nov 14
Third quarter 2021 earnings released The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €210.9m (up 56% from 3Q 2020). Net income: €5.90m (up €5.70m from 3Q 2020). Profit margin: 2.8% (up from 0.1% in 3Q 2020). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • May 12
Investor sentiment improved over the past week After last week's 15% share price gain to €3.07, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 19x in the Chemicals industry in Germany. Total loss to shareholders of 25% over the past three years. Reported Earnings • Mar 02
Full year 2020 earnings released: EPS €0.061 (vs €0.29 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €585.3m (down 13% from FY 2019). Net income: €6.26m (down 80% from FY 2019). Profit margin: 1.1% (down from 4.6% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Analyst Estimate Surprise Post Earnings • Mar 02
Revenue beats expectations Revenue exceeded analyst estimates by 3.0%. Over the next year, revenue is forecast to grow 5.8%, compared to a 5.5% growth forecast for the Chemicals industry in Germany. Is New 90 Day High Low • Feb 18
New 90-day high: €2.47 The company is up 22% from its price of €2.02 on 20 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. Annonce • Jan 29
Ercros, S.A. to Report Fiscal Year 2020 Results on Feb 27, 2021 Ercros, S.A. announced that they will report fiscal year 2020 results on Feb 27, 2021 Is New 90 Day High Low • Jan 07
New 90-day high: €2.40 The company is up 27% from its price of €1.89 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. Valuation Update With 7 Day Price Move • Nov 27
Market bids up stock over the past week After last week's 18% share price gain to €2.38, the stock is trading at a trailing P/E ratio of 10.1x, up from the previous P/E ratio of 8.6x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 2.4%. Is New 90 Day High Low • Nov 24
New 90-day high: €2.19 The company is up 7.0% from its price of €2.05 on 25 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 8.0% over the same period. Annonce • Aug 16
Ercros, S.A. to Report Q2, 2020 Results on Aug 31, 2020 Ercros, S.A. announced that they will report Q2, 2020 results on Aug 31, 2020 Annonce • Jun 29
Ercros, S.A. to Report Q2, 2020 Results on Jul 31, 2020 Ercros, S.A. announced that they will report Q2, 2020 results on Jul 31, 2020